Meier-Kriesche Herwig-Ulf, Schold Jesse D
Department of Medicine, University of Florida, Gainesville, Florida 32610-0224, USA.
Semin Dial. 2005 Nov-Dec;18(6):499-504. doi: 10.1111/j.1525-139X.2005.00096.x.
Dialysis is the most common therapeutic intervention for patients with end-stage renal disease (ESRD). The demonstration of a clear survival benefit associated with renal transplantation has made it the preferred treatment option for ESRD patients medically cleared for transplant. This has invoked a shift in thinking regarding the timing of transplantation. Impaired renal function and particularly ESRD with dialysis are significant cardiovascular risk factors for this population. Part of these cumulative effects can probably be avoided by transplantation without prior dialysis. In fact, the evidence to date demonstrates a significant advantage for allograft and patient survival associated with preemptive transplantation. In addition, preemptive transplantation is associated with better quality of life for these patients and is less costly than dialysis. The key for patients approaching ESRD is early referral to a transplant center to explore the most appropriate treatment options in a timely fashion. In fact, it is better to transplant patients preemptively than to wait until they reach ESRD and start dialysis.
透析是终末期肾病(ESRD)患者最常见的治疗干预措施。肾移植具有明显的生存获益,这使其成为医学上适合移植的ESRD患者的首选治疗方案。这引发了关于移植时机的观念转变。肾功能受损,尤其是接受透析的ESRD,是该人群重要的心血管危险因素。通过无需预先透析的移植可能可以避免部分这些累积影响。事实上,迄今为止的证据表明,抢先移植对同种异体移植物和患者生存具有显著优势。此外,抢先移植对这些患者的生活质量更好,且成本低于透析。对于接近ESRD的患者,关键是尽早转诊至移植中心,以便及时探索最合适的治疗方案。实际上,对患者进行抢先移植比等到他们发展至ESRD并开始透析更好。